|
|
Expression and clinical significance of FAP and FSP1 in papillary thyroid carcinoma |
CAI Li1, HU Jinchen2, JIANG Lei1, QU Guimei1, JIANG Lixin3, ZHENG Haitao3 |
1 Department of Pathology,Affiliated Yuhuangding Hospital of Qingdao University Medical College,Yantai 264003,P.R.China;
2 Department of Thyroid Surgery,Affiliated Yuhuangding Hospital of Qingdao University Medical College;
3 Department of Gastrointestinal Surgery,Affiliated Yuhuangding Hospital of Qingdao University Medical College |
|
|
Abstract Objective To observe the expression of fibroblast-activated protein (FAP) and fibroblast-specific protein 1 (FSP1) in carcinoma-associated fibroblasts (CAFs) of papillary thyroid carcinoma (PTC),and investigate the correlation between CAFs and PTC.Methods The expression of FAP and FSP1 in PTC,normal thyroid was detected by immunohistochemistry, and the clinicopathologicaI correlation was analyzed.Results FAP and FSP1 didn’t express in normal thyroid,but did in PTC.The positive expressions of FAP and FSP1 were in accord with cancerous fibrous response around PTC cells.In PTC,the expression of FAP was positively related to tumor diameter,lymph node metastasis and TNM staging, but the expression of FSP1 was negatively related to the clinicopathological parameter.Conclusion FAP and FSP1 were the senstive markers of carcinoma-associated fibroblasts(CAFs) in PTC.FAP may be certain significant to predict the malignant biological behavior in PTC.
|
Received: 05 August 2018
|
|
|
|
|
[1] Singh S R,Rameshwar P,Siegel P.Targeting tumor microenvironment in cancer therapy[J].Cancer Lett,2016,380(1):203-204.
[2] Hasebe T,Sasaki S,Imoto S,et al.Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of breast[J].Am J Pathol,2000,156(5):1701-1710.
[3] 郑华,申俊, 高庆红,等.口腔鳞状细胞癌间质成纤维细胞α-SMA的表达及意义[J].国际口腔医学杂志,2007,34(3):157-159,230.
[4] Valcz G,Sipos F,Tulassay Z,et al.Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology[J].J Clin Pathol,2014,67(12):1026-1031.
[5] Brennen W N,Isaacs J T,Denmeade S R.Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy[J].Mol Cancer Ther,2012,11(2):257-266.
[6] Zhang J,Chen L,Liu X,et al.Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens[J].Cancer Res,2013,73(9):2770-2781.
[7] Osterreicher C H,Penz-Osterreicher M,Grivennikov S I,et al.Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver[J].Proc Natl Acad Sci U S A,2011,108(1):308-313.
[8] Bhowmick N A,Moses H L.Tumor-stroma interactions[J].CurrOpin Genet Dev,2005,15(1):97-101.
[9] Goicoechea S M,Garcia- Mata R,Staub J,et al.Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts[J].Oncogene,2014,33(10):1265-1273.
[10] Wallace J A,Li F,Balakrishnan S,et al.Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer[J].PLoS One,2013, 8(8):e71533.
[11] Quail D F,Joyce J A.Microenvironmental regulation of tumour progression and metastasis[J].Nat Med,2013,19(11):1423-1437.
[12] Goscinski M A,Suo Z,Fl renes V A,et al.FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions[J].Ultrastruct Pathol,2008,32(3):89-96.
[13] Cohen S J,Alpaugh R K,Palazzo I,et al.Fibroblast activation protein and its relationship to clinical outcome inpancreatic adenocarcinoma[J].Pancreas,2008,37(2):154-158.
[14] Grum-Schwensen B,Klingelhofer J,Berg C H,et al.Suppression of tumor development and metastasis formation in mice lacking the S100A4 (mtsl) gene[J].Cancer Res,2005,65(9):3772-3780.
[15] Kraman M,Bambrough P J,Arnold J N,el al.Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha[J].Science,2010,330(6005):827-830.
[16] Brennen W N,Rosen D M,Wang H,et al.Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug[J].J Natl Cancer Inst,2012,104(17):1320-1334. |
|
|
|